Own products (APIs) for the generic pharmaceutical industry.
We provide quality products and services, consistently,
reliably responsibly and continuously applying some of the world’s
most difficult to handle chemical technologies.
Our independent one-site,
single entity corporate setup enables
Synthesis: Manufacturing services and products for all user industries,
using Archimica´s highly differentiated setup and technologies
APIs, Building blocks, GMP intermediates, Regulatory Starting Materials
For all global markets including the United States of America,
in total Archimica products reach 25 countries.
Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.
Our core business sectors include custom synthesis and Generic API manufacturing.
The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.
We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.
Pepceuticals Limited, established in 1998, is a specialist British manufacturer of synthetic peptides. We remain dedicated to supplying the Life Science industry with high-quality custom peptides and an antibody manufacturing service. Over the years, Pepceuticals has established a reputation for excellence in the field of peptide synthesis, having developed novel technologies that allow us to prepare complex peptide molecules. We are committed to providing solutions to researchers globally by continuing to increase our development program of large and small synthetic peptide libraries, and enhancing the prospects of obtaining new research candidates.
We provide a comprehensive drug development program that allows us to furnish peptides manufactured under cGMP, from milligram to kilogram quantities and to support all aspects of peptide manufacture. Furthermore, we also have an active program to develop generic peptide active substances (API’s) that cover many different disease areas.
At Pepceuticals, we operate a stringent Pharmaceutical Quality System which verifies that the products we supply meet or exceed industry standards. Pepceuticals holds an API manufacturing licence as granted by the MHRA (Medicines and Healthcare Products Regulatory Agency) and BSI ISO 2001-2015 accreditation from the British Standards Industry (BSI) for our manufacturing practices. Our Quality Control (QC) team, ensure that our instrumentation, operating/ testing, and staff training are maintained and continually updated to achieve these high standards. Our aim is to deliver all our products in a reliable time frame with a full certificate of analysis and supporting data.
We ensure effective project management and good communication with all our clients; from sales to product delivery we aspire to offer a complete solution. We trust that you will enjoy the benefits of working with Pepceuticals, as a reliable, flexible and innovative peptide manufacturer.
With almost 175 years of experience in the field of natural products, Ransom Naturals Ltd (RNL) is a leading developer and manufacturer of botanical extracts for the Pharmaceutical, Healthcare, Personal Care and Food & Beverage industries.
Our product portfolio includes active pharmaceutical ingredients (APIs), excipients and botanical extracts which deliver flavour and functionality in food and beverages. In 2007, the Company achieved GMP (Good Manufacturing Practice) accreditation, becoming one of the first UK based pharmaceutical companies manufacturing Herbal Extracts as Active Pharmaceutical Ingredients to receive this quality standard. Our facility, a short distance north of London, is a GMP compliant site approved by the Medicines and Health Regulatory Authority of the United Kingdom.
With a vast amount of natural product experience we are strong in product, process and method development, from laboratory initiation through scale up to full commercial production. Sound finished formulation knowledge means we are perfectly positioned to deliver customer specific project solutions in full and on time. In addition, we also characterise, quantify and standardise APIs to the exacting requirements of a wide range of pharmacopeial and/or customer in house specifications. Furthermore, we offer a full regulatory support service up to and including license submission. Our products are available in liquid, semi-solid (soft) and powdered formats to satisfy the needs of different markets.
Ransom Naturals has successfully partnered traditional methods with an innovative approach to new product development. It has done so by adapting and harnessing the latest in scientific techniques in order to continue to meet the ever-changing needs of markets and customers while staying true to its natural heritage. Proud of its past but looking to the future, RNL serves a wide range of international markets.
As a leading distributor, Ubichem partner with manufacturers across a global supply chain to offer customers an extremely diverse product range of outstanding APIs, Excipients, Intermediates and Fine Chemicals. Our leading portfolio of suppliers and solutions includes some of the most trusted names in the industry’s we serve, such as DSM, Symrise, Vanderbilt, Symbiotica, to name a few.
With decades of product and application expertise combined with deep market trend analysis and regulatory knowledge we help our suppliers and customers to succeed. What’s more, through new product development, our customers benefit from significant commercial opportunities. And with agile manufacturing we provide a comprehensive end-to-end service of design and development, sourcing, conversion, warehousing, and distribution.
We call it ‘Ultimate Customer Value’ and it’s in our DNA.